NSECertificate under SEBI (Depositories and Participants) Regulations, 20181d ago · 13 Oct 2026, 02:03 pm
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Marksans Pharma Limited · MARKSANS
✦ AI Summary
Marksans Pharma Limited has received a certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities up to September 30, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Marksans Pharma Limited has informed the Exchange about Certificate under regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter and half year ended September 30, 2026
Attachments (1)
📄pdf
Download →
MARKSANS_13102026140319_SEintimation.pdf
View document text
Date: October 13, 2026
BSE Limited National Stock Exchange of India Limited
Corporate Relation Department Listing Department
Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block-G,
Dalal Street, Bandra-Kurla Complex,
Mumbai - 400001. Bandra (East), Mumbai - 400051.
Scrip Code: 524404 Symbol: MARKSANS
Sub: Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.
Dear Sir/Madam,
Kindly find enclosed herewith the certificate under Regulation 74(5) of SEBI (Depositories and
Participants) Regulations, 2018 for the quarter and half year ended September 30, 2026 received
from Bigshare Services Private Limited, Registrar and Transfer Agent of the Company.
You are requested to note the above in your records.
Thanking You.
Yours faithfully,
For Marksans Pharma Limited
Harshavardhan Panigrahi
Company Secretary
Encl: As Above
Marksans Pharma Ltd.
11th Floor, "GRANDEUR", Opp. Gundecha Symphony, Veera Desai Extension Road, Oshiwara, Andheri (W),
Mumbai - 400 053 Tel.: +91 22 4001 2000
E-mail: companysecretary@marksanspharma.com
www.marksanspharma.com
Ref No. BSS/74(5)
Date: 09/10/2026
MARKSANS PHARMA LTD FV 1
11TH FLOOR, GRANDEUR
VEERA DESAI, EXTENSION ROAD
OSHIWARA, ANDHERI WEST
MUMBAI 400053
Dear Sir/Madam,
Sub: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations,
2018 for the quarter ended 30th September 2026.
Ref: NSDL/CIR/II/5/2019 dated 25th January 2019 DSL/OPS/RTA/POLICY/2019/14 dated 25th
January 2019. SEBI vide its letter ref no. MRD/DOP2/DSA2/OW/2019/2498/1 dated 24/01/2019
In reference to the above – captioned regulation we hereby confirm that the securities received
from the depository Participants for dematerialization up to 30th September 2026 were
confirmed (accepted/rejected) to the depositories by us and that securities comprised in the said
certificates have been listed on the stock exchange where the earlier issued securities are listed.
We hereby confirm that the security certificates received for dematerialization have been
mutilated & cancelled after due verification by the depository Participant and the name of the
depositories have been substituted in register of members as registered owner within 15 days of
receipt of certificate of securities.
We request you to kindly take note of the above in your records.
Thanking you,
Yours faithfully,
For BIGSHARE SERVICES PVT LTD.
Sandeep More
Authorised Signatory.
CIN – U99999MH1994PTC076534
Regd. Office: Office No. S6-2, 6th Floor, Pinnacle Business Park, Next to Ahura Centre, Mahakali Caves Road,
Andheri (EAST), Mumbai – 400 093. Email: info@bigshareonline.com | Tel. No. +91-22-62638200| website:
www.bigshareonline.com